As part of a global partnership with Nestlé Health Science, VALBIOTIS initiates the pivotal late stage development phase of TOTUM-63, a plant-derived active substance with clinically demonstrated metabolic health benefits in people with prediabetes
(WorldNews France)

PRESS RELEASE As part of a global partnership with Nestlé Health Science, VALBIOTIS initiates the pivotal late stage development phase of TOTUM-63, a plant-derived active substance with clinically demonstrated metabolic health benefits in people with prediabetes This last pivotal trial (REVERSE-IT), has been designed jointly with Nestlé Health Science`s teams and will be entirely funded by the partnership agreement; This international trial will include 600 participants and should be launched before mid-2020; Its first objective is to confirm the positive results of the Phase II clinical trial on fasting blood sugar levels, a well-established risk factor for developing Type 2 Diabetes, to...